Clinical Trial Update: VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination [Phase 4]

View source ↗

Summary

Phase 4 study examining Varicella Zoster Virus–specific tissue-resident memory T cells after Shingrix vaccination; the trial is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Varicella Zoster Virus Infection

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: University of Washington | Conditions: Varicella Zoster Virus Infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING